查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1611410

單細胞多組體學市場：按類型、技術、應用和最終用戶分類 - 2025-2030 年全球預測

Single-Cell Multi-Omics Market by Type (Single Cell Genomics, Single Cell Metabolomics, Single Cell Proteomics), Technique (Single-Cell Analysis, Single-Cell Isolation & Dispensing), Application, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年單細胞多組體學市值為29.2億美元，預計2024年將達到31.8億美元，複合年成長率為10.65%，預計到2030年將達到59.3億美元。

單細胞多組體學是一個新興領域，透過在單細胞層級同時分析基因組、轉錄組、蛋白質組和表觀基因訊息，在理解生物系統的複雜性方面具有巨大潛力。該技術在癌症研究、免疫學和個人化醫療等領域至關重要。對單細胞多組體學的需求源於提供單一細胞的詳細分子藍圖的能力，使研究人員能夠了解細胞異質性並可能徹底改變診斷和治療方法，從而可以識別某些稀有細胞群。應用涵蓋藥物發現、生物標記識別和疾病途徑分析等各個領域。受影響最大的最終用途領域包括製藥公司、學術研究機構和生技公司。影響該市場的關鍵成長要素包括定序技術的進步、政府對基因組研究的資助增加以及對精準醫療的日益關注。在亞太地區等生物技術領域成長迅速的地區，成長機會尤其成熟，醫療基礎設施的擴大和生物技術研究投資的增加預計將推動市場擴張。然而，市場面臨高成本、資料解釋複雜以及對先進生物資訊學能力的需求等挑戰。為了充分利用潛在的商機，公司應專注於開發具有成本效益的解決方案，增強資料分析軟體，並與學術和研究機構建立策略聯盟。創新和研發領域包括提高單細胞多組體學平台的靈敏度和準確性、開發更有效的資料整合工具以及發現農業和環境科學的新應用。市場仍然充滿活力和競爭，需要持續的技術進步和策略適應性，以滿足不斷變化的研究和臨床需求。為了持續成長，我們也應該投資教育舉措，以提高人們對單細胞多體學在各個科學領域潛力的認知和理解。

主要市場統計
基準年[2023] 29.2億美元
預計年份 [2024] 31.8億美元
預測年份 [2030] 59.3億美元
複合年成長率（%） 10.65%

市場動態：揭示快速發展的單細胞多組體學市場的關鍵市場洞察

單細胞多組體學市場正因供需的動態交互作用而轉變。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 全球癌症和慢性病患者數量增加
    • 在單細胞體學中利用計算工具和生物資訊策略
    • 需要採用單細胞多組體學來加速藥物發現和藥物開發
  • 市場限制因素
    • 多組體學計劃高成本且缺乏熟練人員
  • 市場機會
    • 在單細胞多組體學技術中採用人工智慧和機器學習
    • 表觀基因、表觀轉錄組和其他新體學的出現
  • 市場問題
    • 分析大型資料集的困難，對病患資料隱私的擔憂

波特五力：駕馭單細胞多組體學市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架描述了評估公司競爭和探索策略機會的清晰方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解單細胞多組體學市場的外部影響

外部宏觀環境因素在塑造單細胞多組體學市場的績效動態發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析：了解單細胞多組體學市場的競爭格局

對單細胞多組體學市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、細分和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣：單細胞多組體學市場供應商績效評估

FPNV定位矩陣是評估單細胞多組體學市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議：繪製單細胞多組體學市場的成功之路

對於希望加強在全球市場的影響力的公司來說，單細胞多組體學市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

該報告對涵蓋關鍵焦點細分市場的市場進行了全面分析。

1. 市場滲透率：詳細檢視當前市場環境，主要企業的廣泛資料，評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有細分市場的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、主要產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策。

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品和地區提供最佳投資機會？

3.塑造市場的關鍵技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 世界各地的癌症和慢性病病例正在增加
      • 利用計算工具和生物資訊策略進行單細胞體學
      • 需要採用單細胞多組體學來加速藥物發現和開發
    • 抑制因素
      • 多體學計劃高成本且缺乏熟練人員
    • 機會
      • 在單細胞多組體學技術中採用人工智慧和機器學習
      • 表觀基因、表觀轉錄組和其他新體學的出現
    • 任務
      • 難以分析大型資料集以及對病患​​資料隱私的擔憂
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 經濟
    • 社會
    • 科技
    • 法律
    • 環境

第6章單細胞多組體學市場：依類型

  • 介紹
  • 單細胞基因體學
  • 單細胞代謝體學
  • 單細胞蛋白質體學
  • 單細胞轉錄組學

第7章單細胞多組體學市場：依技術分類

  • 介紹
  • 單細胞分析
  • 單細胞分離與分配

第8章單細胞多組體學市場：依應用分類

  • 介紹
  • 細胞生物學
  • 免疫學
  • 神經病學
  • 腫瘤學
  • 幹細胞研究

第 9 章 單細胞多組體學市場：依最終使用者分類

  • 介紹
  • 學術機構
  • 合約研究組織
  • 製藥和生物技術公司

第10章美洲單細胞多組體學市場

  • 介紹
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太單細胞多組體學市場

  • 介紹
  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲的單細胞多組體學市場

  • 介紹
  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • 10x Genomics
  • Agilent Technologies, Inc.
  • Akoya Biosciences
  • Becton, Dickinson and Company
  • Berkeley Lights Inc.
  • BGI Genomics Co., Ltd.
  • Bio-Rad Laboratories, Inc.
  • Bruker Corporation
  • Cytena by Bico Group
  • Danaher Corporation
  • Dolomite Bio
  • Epicypher Inc.
  • Illumina, Inc
  • Merck KGaA
  • Miltenyi BIoTec BV & CO.
  • Mission Bio, Inc.
  • Nanostring Technologies, Inc.
  • Olink Holding AB
  • Parse Bioscience
  • Qiagen NV
  • Standard BioTools Inc.
  • Takara Holdings Inc.
  • Thermo Fisher Scientific Inc.
  • Vizgen Inc.
Product Code: MRR-7C31448F0BAB

The Single-Cell Multi-Omics Market was valued at USD 2.92 billion in 2023, expected to reach USD 3.18 billion in 2024, and is projected to grow at a CAGR of 10.65%, to USD 5.93 billion by 2030.

Single-cell multi-omics is an emerging field with significant potential in understanding the complexity of biological systems by simultaneously analyzing genomic, transcriptomic, proteomic, and epigenomic information at the single-cell level. This technique is critical in fields like cancer research, immunology, and personalized medicine. The necessity for single-cell multi-omics arises from its ability to provide a detailed molecular blueprint of individual cells, thus allowing researchers to comprehend cellular heterogeneity and identify rare cell populations, which could revolutionize diagnostics and therapeutics. Applications span across various segments, including drug discovery, biomarker identification, and disease pathway analysis. End-use sectors prominently impacted include pharmaceutical companies, academic research institutions, and biotechnology firms. Key growth factors influencing this market include advancements in sequencing technologies, increasing government funding for genomics research, and a rising focus on precision medicine. Opportunities for growth are particularly ripe in regions with burgeoning biotech sectors, like Asia-Pacific, where expanding healthcare infrastructure and growing investments in biotechnological research are expected to drive market expansion. However, the market faces challenges such as high costs associated with the technology, complex data interpretation, and the need for advanced bioinformatics capabilities. To capitalize on potential opportunities, companies should focus on developing cost-effective solutions, enhancing data analysis software, and forming strategic collaborations with academic and research institutions. Areas for innovation and research include improving the sensitivity and accuracy of single-cell multi-omics platforms, developing more effective data integration tools, and discovering novel applications in agriculture and environmental sciences. The market remains dynamic and highly competitive, necessitating continuous technological advancements and strategic adaptability to align with evolving research and clinical demands. For sustained growth, businesses should also invest in educational initiatives to increase awareness and understanding of the potential of single-cell multi-omics across various scientific sectors.

KEY MARKET STATISTICS
Base Year [2023] USD 2.92 billion
Estimated Year [2024] USD 3.18 billion
Forecast Year [2030] USD 5.93 billion
CAGR (%) 10.65%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Single-Cell Multi-Omics Market

The Single-Cell Multi-Omics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising number of cancer cases and chronic disorders globally
    • Utilization of computational tools and bioinformatics strategies for single-cell omics
    • Need for adoption of single-cell multi-omics to accelerate drug discovery and development
  • Market Restraints
    • High cost of multi-omics projects and lack of skilled personnel
  • Market Opportunities
    • Adoption of AI and ML in single-cell multi-omics technologies
    • Emergence of epigenome, epitranscriptome, and other new omics
  • Market Challenges
    • Difficult of analyzing large datasets and concerns associated with privacy of patient data

Porter's Five Forces: A Strategic Tool for Navigating the Single-Cell Multi-Omics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Single-Cell Multi-Omics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Single-Cell Multi-Omics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Single-Cell Multi-Omics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Single-Cell Multi-Omics Market

A detailed market share analysis in the Single-Cell Multi-Omics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Single-Cell Multi-Omics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Single-Cell Multi-Omics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Single-Cell Multi-Omics Market

A strategic analysis of the Single-Cell Multi-Omics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Single-Cell Multi-Omics Market, highlighting leading vendors and their innovative profiles. These include 10x Genomics, Agilent Technologies, Inc., Akoya Biosciences, Becton, Dickinson and Company, Berkeley Lights Inc., BGI Genomics Co., Ltd., Bio-Rad Laboratories, Inc., Bruker Corporation, Cytena by Bico Group, Danaher Corporation, Dolomite Bio, Epicypher Inc., Illumina, Inc, Merck KGaA, Miltenyi Biotec B.V. & CO., Mission Bio, Inc., Nanostring Technologies, Inc., Olink Holding AB, Parse Bioscience, Qiagen NV, Standard BioTools Inc., Takara Holdings Inc., Thermo Fisher Scientific Inc., and Vizgen Inc..

Market Segmentation & Coverage

This research report categorizes the Single-Cell Multi-Omics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Single Cell Genomics, Single Cell Metabolomics, Single Cell Proteomics, and Single Cell Transcriptomics.
  • Based on Technique, market is studied across Single-Cell Analysis and Single-Cell Isolation & Dispensing.
  • Based on Application, market is studied across Cell Biology, Immunology, Neurology, Oncology, and Stem Cell Research.
  • Based on End User, market is studied across Academic Institutes, Contract Research Organizations, and Pharmaceutical & Biotech Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising number of cancer cases and chronic disorders globally
      • 5.1.1.2. Utilization of computational tools and bioinformatics strategies for single-cell omics
      • 5.1.1.3. Need for adoption of single-cell multi-omics to accelerate drug discovery and development
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of multi-omics projects and lack of skilled personnel
    • 5.1.3. Opportunities
      • 5.1.3.1. Adoption of AI and ML in single-cell multi-omics technologies
      • 5.1.3.2. Emergence of epigenome, epitranscriptome, and other new omics
    • 5.1.4. Challenges
      • 5.1.4.1. Difficult of analyzing large datasets and concerns associated with privacy of patient data
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Single-Cell Multi-Omics Market, by Type

  • 6.1. Introduction
  • 6.2. Single Cell Genomics
  • 6.3. Single Cell Metabolomics
  • 6.4. Single Cell Proteomics
  • 6.5. Single Cell Transcriptomics

7. Single-Cell Multi-Omics Market, by Technique

  • 7.1. Introduction
  • 7.2. Single-Cell Analysis
  • 7.3. Single-Cell Isolation & Dispensing

8. Single-Cell Multi-Omics Market, by Application

  • 8.1. Introduction
  • 8.2. Cell Biology
  • 8.3. Immunology
  • 8.4. Neurology
  • 8.5. Oncology
  • 8.6. Stem Cell Research

9. Single-Cell Multi-Omics Market, by End User

  • 9.1. Introduction
  • 9.2. Academic Institutes
  • 9.3. Contract Research Organizations
  • 9.4. Pharmaceutical & Biotech Companies

10. Americas Single-Cell Multi-Omics Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Single-Cell Multi-Omics Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Single-Cell Multi-Omics Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 10x Genomics
  • 2. Agilent Technologies, Inc.
  • 3. Akoya Biosciences
  • 4. Becton, Dickinson and Company
  • 5. Berkeley Lights Inc.
  • 6. BGI Genomics Co., Ltd.
  • 7. Bio-Rad Laboratories, Inc.
  • 8. Bruker Corporation
  • 9. Cytena by Bico Group
  • 10. Danaher Corporation
  • 11. Dolomite Bio
  • 12. Epicypher Inc.
  • 13. Illumina, Inc
  • 14. Merck KGaA
  • 15. Miltenyi Biotec B.V. & CO.
  • 16. Mission Bio, Inc.
  • 17. Nanostring Technologies, Inc.
  • 18. Olink Holding AB
  • 19. Parse Bioscience
  • 20. Qiagen NV
  • 21. Standard BioTools Inc.
  • 22. Takara Holdings Inc.
  • 23. Thermo Fisher Scientific Inc.
  • 24. Vizgen Inc.

LIST OF FIGURES

  • FIGURE 1. SINGLE-CELL MULTI-OMICS MARKET RESEARCH PROCESS
  • FIGURE 2. SINGLE-CELL MULTI-OMICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL SINGLE-CELL MULTI-OMICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL SINGLE-CELL MULTI-OMICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL SINGLE-CELL MULTI-OMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS SINGLE-CELL MULTI-OMICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS SINGLE-CELL MULTI-OMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES SINGLE-CELL MULTI-OMICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES SINGLE-CELL MULTI-OMICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC SINGLE-CELL MULTI-OMICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC SINGLE-CELL MULTI-OMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. SINGLE-CELL MULTI-OMICS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. SINGLE-CELL MULTI-OMICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. SINGLE-CELL MULTI-OMICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL SINGLE-CELL MULTI-OMICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL SINGLE-CELL MULTI-OMICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL SINGLE-CELL MULTI-OMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. SINGLE-CELL MULTI-OMICS MARKET DYNAMICS
  • TABLE 7. GLOBAL SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL SINGLE-CELL MULTI-OMICS MARKET SIZE, BY SINGLE CELL GENOMICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL SINGLE-CELL MULTI-OMICS MARKET SIZE, BY SINGLE CELL METABOLOMICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL SINGLE-CELL MULTI-OMICS MARKET SIZE, BY SINGLE CELL PROTEOMICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL SINGLE-CELL MULTI-OMICS MARKET SIZE, BY SINGLE CELL TRANSCRIPTOMICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL SINGLE-CELL MULTI-OMICS MARKET SIZE, BY SINGLE-CELL ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL SINGLE-CELL MULTI-OMICS MARKET SIZE, BY SINGLE-CELL ISOLATION & DISPENSING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL SINGLE-CELL MULTI-OMICS MARKET SIZE, BY CELL BIOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL SINGLE-CELL MULTI-OMICS MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL SINGLE-CELL MULTI-OMICS MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL SINGLE-CELL MULTI-OMICS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL SINGLE-CELL MULTI-OMICS MARKET SIZE, BY STEM CELL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL SINGLE-CELL MULTI-OMICS MARKET SIZE, BY ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL SINGLE-CELL MULTI-OMICS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL SINGLE-CELL MULTI-OMICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECH COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS SINGLE-CELL MULTI-OMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES SINGLE-CELL MULTI-OMICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC SINGLE-CELL MULTI-OMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 58. AUSTRALIA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. AUSTRALIA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 62. CHINA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. CHINA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 66. INDIA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. INDIA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 70. INDONESIA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. INDONESIA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 74. JAPAN SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. JAPAN SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 78. MALAYSIA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. MALAYSIA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 82. PHILIPPINES SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. PHILIPPINES SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 86. SINGAPORE SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. SINGAPORE SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH KOREA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH KOREA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 94. TAIWAN SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. TAIWAN SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 98. THAILAND SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. THAILAND SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 102. VIETNAM SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. VIETNAM SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 111. DENMARK SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. DENMARK SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 115. EGYPT SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. EGYPT SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 119. FINLAND SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. FINLAND SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 123. FRANCE SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. FRANCE SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 127. GERMANY SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. GERMANY SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 131. ISRAEL SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. ISRAEL SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 135. ITALY SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. ITALY SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 139. NETHERLANDS SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. NETHERLANDS SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 143. NIGERIA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. NIGERIA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 147. NORWAY SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 148. NORWAY SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 151. POLAND SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 152. POLAND SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 155. QATAR SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 156. QATAR SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 159. RUSSIA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 160. RUSSIA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 163. SAUDI ARABIA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 164. SAUDI ARABIA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH AFRICA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 168. SOUTH AFRICA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 171. SPAIN SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 172. SPAIN SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 175. SWEDEN SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 176. SWEDEN SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 179. SWITZERLAND SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 180. SWITZERLAND SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 183. TURKEY SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 184. TURKEY SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED ARAB EMIRATES SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED ARAB EMIRATES SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED KINGDOM SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 192. UNITED KINGDOM SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 193. SINGLE-CELL MULTI-OMICS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 194. SINGLE-CELL MULTI-OMICS MARKET, FPNV POSITIONING MATRIX, 2023